Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism; D001923:Brain Chemistry; D002082:Butylamines / Q000008:administration & dosage / Q000494:pharmacology; D002090:Butyrophenones / Q000494:pharmacology; D003984:Dibenzazepines / Q000008:administration & dosage / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D006651:Histocytochemistry; D008297:Male; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D010640:Phenothiazines / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D013116:Spinal Cord / Q000032:analysis / Q000187:drug effects / Q000378:metabolism; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014966:Xanthenes / Q000008:administration & dosage / Q000494:pharmacology
D002082:Butylamines; D002090:Butyrophenones; D003984:Dibenzazepines; D010640:Phenothiazines; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D014966:Xanthenes; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine